Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma.
Alexander BM, Trippa L, Gaffey S, Arrillaga-Romany IC, Lee EQ, Rinne ML, Ahluwalia MS, Colman H, Fell G, Galanis E, de Groot J, Drappatz J, Lassman AB, Meredith DM, Nabors LB, Santagata S, Schiff D, Welch MR, Ligon KL, Wen PY.
Alexander BM, et al. Among authors: fell g.
JCO Precis Oncol. 2019 Mar 27;3:PO.18.00071. doi: 10.1200/PO.18.00071. eCollection 2019.
JCO Precis Oncol. 2019.
PMID: 32914038
Free PMC article.